Literature DB >> 30776012

Is Alzheimer's Disease Risk Modifiable?

Alberto Serrano-Pozo1,2, John H Growdon1,2.   

Abstract

Population-based clinic-pathological studies have established that the most common pathological substrate of dementia in community-dwelling elderly people is mixed, especially Alzheimer's disease (AD) and cerebrovascular ischemic disease (CVID), rather than pure AD. While these could be just two frequent unrelated comorbidities in the elderly, epidemiological research has reinforced the idea that mid-life (age <65 years) vascular risk factors increase the risk of late-onset (age ≥ 65 years) dementia, and specifically AD. By contrast, healthy lifestyle choices such as leisure activities, physical exercise, and Mediterranean diet are considered protective against AD. Remarkably, several large population-based longitudinal epidemiological studies have recently indicated that the incidence and prevalence of dementia might be decreasing in Western countries. Although it remains unclear whether these positive trends are attributable to neuropathologically definite AD versus CVID, based on these epidemiological data it has been estimated that a sizable proportion of AD cases could be preventable. In this review, we discuss the current evidence about modifiable risk factors for AD derived from epidemiological, preclinical, and interventional studies, and analyze the opportunities for therapeutic and preventative interventions.

Entities:  

Keywords:  Alcohol drinking; Alzheimer’s disease; dementia; diabetes mellitus; diet; education; exercise; hyperlipidemia; hypertension; smoking

Mesh:

Year:  2019        PMID: 30776012      PMCID: PMC6708279          DOI: 10.3233/JAD181028

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  281 in total

1.  Mediterranean-style diet and risk of ischemic stroke, myocardial infarction, and vascular death: the Northern Manhattan Study.

Authors:  Hannah Gardener; Clinton B Wright; Yian Gu; Ryan T Demmer; Bernadette Boden-Albala; Mitchell S V Elkind; Ralph L Sacco; Nikolaos Scarmeas
Journal:  Am J Clin Nutr       Date:  2011-11-09       Impact factor: 7.045

2.  Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.

Authors:  Suzanne Craft; Laura D Baker; Thomas J Montine; Satoshi Minoshima; G Stennis Watson; Amy Claxton; Matthew Arbuckle; Maureen Callaghan; Elaine Tsai; Stephen R Plymate; Pattie S Green; James Leverenz; Donna Cross; Brooke Gerton
Journal:  Arch Neurol       Date:  2011-09-12

3.  Associations of vegetable and fruit consumption with age-related cognitive change.

Authors:  M C Morris; D A Evans; C C Tangney; J L Bienias; R S Wilson
Journal:  Neurology       Date:  2006-10-24       Impact factor: 9.910

4.  The Effects of Peripheral and Central High Insulin on Brain Insulin Signaling and Amyloid-β in Young and Old APP/PS1 Mice.

Authors:  Molly Stanley; Shannon L Macauley; Emily E Caesar; Lauren J Koscal; Will Moritz; Grace O Robinson; Joseph Roh; Jennifer Keyser; Hong Jiang; David M Holtzman
Journal:  J Neurosci       Date:  2016-11-16       Impact factor: 6.167

5.  Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial.

Authors:  Sandrine Andrieu; Sophie Guyonnet; Nicola Coley; Christelle Cantet; Marc Bonnefoy; Serge Bordes; Lawrence Bories; Marie-Noëlle Cufi; Thierry Dantoine; Jean-François Dartigues; Françoise Desclaux; Audrey Gabelle; Yannick Gasnier; Alain Pesce; Kristel Sudres; Jacques Touchon; Philippe Robert; Olivier Rouaud; Philippe Legrand; Pierre Payoux; Jean-Paul Caubere; Michael Weiner; Isabelle Carrié; Pierre-Jean Ousset; Bruno Vellas
Journal:  Lancet Neurol       Date:  2017-03-27       Impact factor: 44.182

6.  Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease.

Authors:  Yi-Fei Dong; Keiichiro Kataoka; Yoshiko Tokutomi; Hisato Nako; Taishi Nakamura; Kensuke Toyama; Daisuke Sueta; Nobutaka Koibuchi; Eiichiro Yamamoto; Hisao Ogawa; Shokei Kim-Mitsuyama
Journal:  FASEB J       Date:  2011-05-18       Impact factor: 5.191

7.  Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.

Authors:  Peter P Zandi; D Larry Sparks; Ara S Khachaturian; Joann Tschanz; Maria Norton; Martin Steinberg; Kathleen A Welsh-Bohmer; John C S Breitner
Journal:  Arch Gen Psychiatry       Date:  2005-02

8.  The association between physical activity and dementia in an elderly population: the Rotterdam Study.

Authors:  Renée F A G de Bruijn; Elisabeth M C Schrijvers; Karen A de Groot; Jacqueline C M Witteman; Albert Hofman; Oscar H Franco; Peter J Koudstaal; Mohammad Arfan Ikram
Journal:  Eur J Epidemiol       Date:  2013-02-06       Impact factor: 8.082

9.  Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice.

Authors:  Marta Dobarro; Gorka Gerenu; María J Ramírez
Journal:  Int J Neuropsychopharmacol       Date:  2013-06-17       Impact factor: 5.176

10.  Economic Burden, Mortality, and Institutionalization in Patients Newly Diagnosed with Alzheimer's Disease.

Authors:  Christopher M Black; Howard Fillit; Lin Xie; Xiaohan Hu; M Furaha Kariburyo; Baishali M Ambegaonkar; Onur Baser; Huseyin Yuce; Rezaul K Khandker
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

View more
  16 in total

1.  Analysis of differential gene expression and transcript usage in hippocampus of Apoe null mutant mice: Implications for Alzheimer's disease.

Authors:  Andrew E Weller; Glenn A Doyle; Benjamin C Reiner; Richard C Crist; Wade H Berrettini
Journal:  Neurosci Res       Date:  2021-10-29       Impact factor: 3.304

Review 2.  Nonhuman primates at the intersection of aging biology, chronic disease, and health: An introduction to the American Journal of Primatology Special Issue on aging, cognitive decline, and neuropathology in nonhuman primates.

Authors:  Carol A Shively; Agnès Lacreuse; Brett M Frye; Emily S Rothwell; Manuel Moro
Journal:  Am J Primatol       Date:  2021-08-17       Impact factor: 2.371

3.  Systems Biology to Address Unmet Medical Needs in Neurological Disorders.

Authors:  Masha G Savelieff; Mohamed H Noureldein; Eva L Feldman
Journal:  Methods Mol Biol       Date:  2022

4.  APOE ε4-specific associations of VEGF gene family expression with cognitive aging and Alzheimer's disease.

Authors:  Annah M Moore; Emily Mahoney; Logan Dumitrescu; Philip L De Jager; Mary Ellen I Koran; Vladislav A Petyuk; Renã As Robinson; Douglas M Ruderfer; Nancy J Cox; Julie A Schneider; David A Bennett; Angela L Jefferson; Timothy J Hohman
Journal:  Neurobiol Aging       Date:  2019-11-05       Impact factor: 4.673

Review 5.  Modifiable Risk Factors in Alzheimer Disease and Related Dementias: A Review.

Authors:  Rachel Litke; Lorena Cancino Garcharna; Salima Jiwani; Judith Neugroschl
Journal:  Clin Ther       Date:  2021-06-06       Impact factor: 3.637

6.  Development and validation of the dialysis dementia risk score: A retrospective, population-based, nested case-control study.

Authors:  Tsai-Chieh Ling; Chiung-Chih Chang; Chung-Yi Li; Junne-Ming Sung; Chien-Yao Sun; Kuen-Jer Tsai; Ya-Yun Cheng; Jia-Ling Wu; Yi-Ting Kuo; Yu-Tzu Chang
Journal:  Eur J Neurol       Date:  2021-10-07       Impact factor: 6.288

7.  Longitudinal analysis of risk factors for dementia based on Mild Cognitive Impairment Screen results and questionnaire responses from healthy Japanese individuals registered in an online database.

Authors:  Masayo Ogawa; Kazushi Maruo; Daichi Sone; Hiroyuki Shimada; Keisuke Suzuki; Hiroshi Watanabe; Hiroshi Matsuda; Hidehiro Mizusawa
Journal:  Alzheimers Dement (N Y)       Date:  2019-08-02

8.  Relative Efficacy of a Nutritional Intervention on Cognitive Performance Across the Adult Lifespan and During Early Cognitive Decline.

Authors:  Thomas B Shea; Ruth Remington
Journal:  J Alzheimers Dis Rep       Date:  2019-08-30

9.  High-Fat Diet Modulates Hepatic Amyloid β and Cerebrosterol Metabolism in the Triple Transgenic Mouse Model of Alzheimer's Disease.

Authors:  Cristina R Bosoi; Milène Vandal; Marine Tournissac; Manon Leclerc; Hortense Fanet; Patricia L Mitchell; Mélanie Verreault; Jocelyn Trottier; Jessica Virgili; Cynthia Tremblay; H Robert Lippman; Jasmohan S Bajaj; Olivier Barbier; André Marette; Frédéric Calon
Journal:  Hepatol Commun       Date:  2020-12-18

Review 10.  Dementia Risk Scores and Their Role in the Implementation of Risk Reduction Guidelines.

Authors:  Kaarin J Anstey; Lidan Zheng; Ruth Peters; Scherazad Kootar; Mariagnese Barbera; Ruth Stephen; Tarun Dua; Neerja Chowdhary; Alina Solomon; Miia Kivipelto
Journal:  Front Neurol       Date:  2022-01-04       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.